Integration of Novel Diagnostics into Clinical Practice
C T2023-11-15T12:51:08-05:00June 29th, 2015|Categories: Blog, HEOR Feature|Tags: Avalon Health Economics, biomarkers, Cara Scheibling, clinical practice guidelines, Companion diagnostics, economic value, health services research, John Schneider, pharmaceuticals, specialty pharmaceuticals, tHEORetically Speaking|
By John Schneider, Ph.D Similar to drug and device markets, a critical part of the success of novel [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
Tuesday, December 5, 2023
Sponsor: ICON
EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
Friday, November 10, 2023
Sponsor: OpenHealth
Cell & Gene Therapies – Beginning with the End in Mind
Thursday, November 2, 2023
Sponsor: Magnolia Market Access
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication